|
1
|
Arriagada R, Bergman B, Dunant A, Le
Chevalier T, Pignon JP and Vansteenkiste J; International Adjuvant
Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant
chemotherapy in patients with completely resected non-small-cell
lung cancer. N Engl J Med. 350:351–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics. CA Cancer J Clin. 55:10–30. 2005.
|
|
3
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gangadhar T, Nandi S and Salgia R: The
role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther.
9:409–416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vindrieux D, Escobar P and Lazennec G:
Emerging roles of chemokines in prostate cancer. Endocr Relat
Cancer. 16:663–673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Müller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001.PubMed/NCBI
|
|
7
|
Clapham PR and Weiss RA: Immunodeficiency
viruses. Spoilt for choice of co-receptors. Nature. 388:230–231.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang JJ, Zhu S, Bruggeman R, et al: High
levels of expression of human stromal cell-derived factor-1 are
associated with worse prognosis in patients with stage II
pancreatic ductal adenocacinoma. Cancer Epidemiol Biomarkers Prev.
19:2598–2604. 2010. View Article : Google Scholar
|
|
9
|
Castellone MD, Guarino V, De Falco V, et
al: Functional expression of the CXCR4 chemokine receptor is
induced by RET/PTC oncogenes and is a common event in human
papillary thyroid carcinomas. Oncogene. 23:5958–5967. 2004.
View Article : Google Scholar
|
|
10
|
Torregrossa L, Giannini R, Borrelli N, et
al: CXCR4 expression correlates with the degree of tumor
infiltration and BRAF status in papillary thyroid carcinomas. Mod
Pathol. 25:46–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su L, Zhang J, Xu H, et al: Differential
expression of CXCR4 is associated with the metastatic potential of
human non-small cell lung cancer cells. Clin Cancer Res.
11:8273–8280. 2005. View Article : Google Scholar
|
|
12
|
Spano JP, Andre F, Morat L, et al:
Chemokine receptor CXCR4 and early-stage non-small cell lung
cancer: pattern of expression and correlation with outcome. Ann
Oncol. 15:613–617. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Phillips RJ, Burdick MD, Lutz M, et al:
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4
biological axis in non-small cell lung cancer metastases. Am J
Respir Crit Care Med. 167:1676–1686. 2003. View Article : Google Scholar
|
|
14
|
Phillips RJ, Mestas J, Gharaee-Kermani M,
et al: Epidermal growth factor and hypoxia-induced expression of
CXC chemokine receptor 4 on non-small cell lung cancer cells is
regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian
target of rapamycin signaling pathway and activation of hypoxia
inducible factor-1alpha. J Biol Chem. 280:22473–22481. 2005.
|
|
15
|
Broxmeyer HE, Orschell CM, Clapp DW, et
al: Rapid mobilization of murine and human hematopoietic stem and
progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med.
201:1307–1318. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ok S, Kim SM, Kim C, et al: Emodin
inhibits invasion and migration of prostate and lung cancer cells
by downregulating the expression of chemokine receptor CXCR4.
Immunopharmacol Immunotoxicol. 34:768–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie S, Zeng W, Zuo T, et al: Expression
and significance of CXCR4 chemokine receptor in non small cell lung
cancer. Chin J Gen Pract. 10:1335–1336. 2012.
|
|
18
|
Huang YC, Hsiao YC, Chen YJ, et al:
Stromal cell-derived factor-1 enhances motility and integrin
up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in
human lung cancer cells. Biochem Pharmacol. 74:1702–1712. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng H, Dai T, Zhou B, et al:
SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis
under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis.
201:36–42. 2008. View Article : Google Scholar
|
|
20
|
Abedini F, Ismail M, Hosseinkhani H, et
al: Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4
expression and serum LDH levels in a mouse model of colorectal
cancer metastasis to the liver. Cancer Manag Res. 3:301–309.
2011.PubMed/NCBI
|
|
21
|
Orimo A, Gupta PB, Sgroi DC, et al:
Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12
secretion. Cell. 121:335–348. 2005. View Article : Google Scholar
|
|
22
|
Rubie C, Frick VO, Ghadjar P, et al: CXC
receptor-4 mRNA silencing abrogates CXCL12-induced migration of
colorectal cancer cells. J Transl Med. 9:222011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee W, Jiang Z, Liu J, Haverty PM, Guan Y,
Stinson J, et al: The mutation spectrum revealed by paired genome
sequences from a lung cancer patient. Nature. 465:473–477. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wald O, Izhar U, Amir G, et al:
Interaction between neoplastic cells and cancer-associated
fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell
lung cancer tumor proliferation. J Thorac Cardiovasc Surg.
141:1503–1512. 2011. View Article : Google Scholar
|
|
25
|
Sun YX, Wang J, Shelburne CE, et al:
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers
(PCa) in vivo. J Cell Biochem. 89:462–473. 2003. View Article : Google Scholar : PubMed/NCBI
|
